4D Molecular Therapeutics, Inc. — All Filings
385 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-129156 | Mar 27, 2026 | Mar 25, 2026 |
| 4 | 4 | 0001193125-26-129155 | Mar 27, 2026 | Mar 25, 2026 |
| 4 | 4 | 0001193125-26-129154 | Mar 27, 2026 | Mar 25, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-000363 | Mar 26, 2026 | — |
| 4 | 4 | 0001193125-26-122341 | Mar 24, 2026 | Mar 20, 2026 |
| S-8 | S-8 | 0001193125-26-114200 | Mar 18, 2026 | — |
| 10-K | 10-K | 0001193125-26-114075 | Mar 18, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-113949 | Mar 18, 2026 | — |
| SCHEDULE 13G/A | — | 0001388325-26-000011 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001346824-26-000029 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000921895-26-000459 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-022559 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | 4 | 0001193125-26-006809 | Jan 7, 2026 | Jan 5, 2026 |
| 3 | 3 | 0001193125-26-006805 | Jan 7, 2026 | Jan 5, 2026 |
| 8-K | 8-K | 0001193125-26-005470 | Jan 7, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-25-331299 | Dec 23, 2025 | Dec 20, 2025 |
| 3 | 3 | 0001193125-25-326864 | Dec 19, 2025 | Dec 9, 2025 |
| 4 | 4 | 0001193125-25-326851 | Dec 19, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-320992 | Dec 16, 2025 | Dec 12, 2025 |
| 144 | — | 0001950047-25-010414 | Dec 16, 2025 | — |
| 4 | 4 | 0001193125-25-315989 | Dec 11, 2025 | Dec 9, 2025 |
| 3 | 3 | 0001193125-25-315962 | Dec 11, 2025 | Dec 9, 2025 |
| 8-K | 8-K | 0001193125-25-314167 | Dec 10, 2025 | — |
| 4 | 4 | 0001193125-25-288632 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0001950047-25-008964 | Nov 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-283861 | Nov 17, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273343 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-273340 | Nov 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-272286 | Nov 7, 2025 | Nov 6, 2025 |
| 424B5 | 424B5 | 0001193125-25-269700 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-267934 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-259302 | Oct 31, 2025 | — |
| 4 | 4 | 0001193125-25-251874 | Oct 27, 2025 | Oct 24, 2025 |
| 144 | — | 0001950047-25-008163 | Oct 24, 2025 | — |
| 4 | 4 | 0001193125-25-243946 | Oct 20, 2025 | Oct 16, 2025 |
| SCHEDULE 13G | — | 0001388325-25-000011 | Oct 20, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-002576 | Oct 17, 2025 | — |
| 4 | 4 | 0001193125-25-238995 | Oct 14, 2025 | Oct 9, 2025 |
| 3 | 3 | 0000950130-25-000195 | Oct 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-228289 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-221028 | Sep 26, 2025 | Sep 23, 2025 |
| 144 | — | 0001950047-25-007439 | Sep 23, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106244 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106243 | Aug 11, 2025 | — |
| 8-K | 8-K | 0000950170-25-092964 | Jul 2, 2025 | Jun 27, 2025 |
| 4 | 4 | 0000950170-25-088497 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-088496 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-088489 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-088487 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-088486 | Jun 20, 2025 | Jun 17, 2025 |